Cosmo Pharmaceuticals N.V. (LON:0RGI)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	688	901	763	900	895	1,018
Market Cap Growth	18.10%	18.10%	-15.23%	0.57%	-12.08%	16.39%
Enterprise Value	574	795	727	864	864	956
Last Close Price	42.77	56.12	46.53	52.75	49.58	65.57
PE Ratio	6.24	8.18	-	58.91	49.16	-
PS Ratio	3.12	4.08	9.48	9.94	16.37	18.64
PB Ratio	1.65	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	2.66	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	5.27	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	5.12	6.71	38.72	30.54	84.48	87.48
EV/Sales Ratio	2.52	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	4.18	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	4.52	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	4.40	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.00	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.01	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.01	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.46	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.27	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.39	3.39	3.22	1.45	11.77	11.06
Current Ratio	4.19	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	29.31%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	15.87%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Capital (ROIC)	20.39%	20.39%	-0.22%	2.66%	1.11%	0.20%
Return on Capital Employed (ROCE)	24.90%	24.90%	-	5.00%	1.40%	0.30%
Earnings Yield	16.02%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	18.98%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	3.55%	3.02%	3.73%	1.77%	1.61%	-
Payout Ratio	24.09%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-1.94%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	1.61%	1.08%	5.68%	4.60%	-15.20%	1.11%

Updated Jul 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.